Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC) — Stella

View on ClinicalTrials.gov

Recruiting

Back to Coloboma trials

Trial locations(1 site)

United States

National Institutes of Health Clinical Center, Bethesda, Maryland

Key details

Sponsor

National Eye Institute (NEI)

Enrollment target

~600 participants

Started

January 2013

Primary completion

December 2027

Age range

1 Year – 100 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.